Ophthalmology

Nancy Holekamp, MD discusses the substantial emotional burden and impact on independence of GA reported in the Geographic Atrophy Insights Survey.

71.6% of patients showed a clinically meaningful improvement in total corneal fluorescein staining at 4 weeks after using the ophthalmic solution.

Dexamethasone as a first-line treatment for DME may increase economic costs in settings where bevacizumab is used off-label, but lower annual costs compared with aflibercept.

Data show visual display terminal use causes dry eye disease mainly through impaired blinking patterns.

Pregnant women with preexisting T1D or T2D had a higher rate of any DR and a higher DR progression rate compared to the nonpregnant population.

However, initially observed eyes were found more at risk of developing moderate visual loss and more than 80% required treatment over 24 months.

Socioeconomic factors beyond race and ethnicity may play important role in determining prematurity and ROP risk.

Investigators noted selection bias and unaccounted-for confounders may make the increase in RVO incidence coincidental to COVID-19 infection.

Data show at-home VA test results from printed chart, mobile phone app, and website were validated within 1 line to in-office measurements.

The study shows fenofibrate use was associated with a lower risk of progression to PDR and VTDR, but not DME alone.

Data show a combined increase in the risk of SRD, RVO, and ION associated with the use of PDE5Is in older men.

Mean follow-up IOP was similar between groups, with a median of 15.83 mm Hg among patients with glaucoma versus 14.94 mm Hg among healthy participants.

An ophthalmologist provides insight into the harms of excessive blue light, and simple consumer resolutions.

The primary endpoint of improving near vision without compromising distance vision at Day 14, Hour 9 was met.

Female academic ophthalmologists were paid a mean of $50,300 less than male peers.

The resolution of excess central retinal thickness in response to anti-VEGF therapy and the treatment burden were additionally similar between the 2 groups.

The lens is added to a patient’s eye through a quick surgical procedure with no removal of corneal tissue and can be removed by a doctor if desired.

After more promising long-term data, Apellis announced plans to seek regulatory approval. An investigator explains what value it could bring to patients.

Deep learning analyses of photographic images and other test results in clinical trials may reduce cost and improve the consistency and accuracy of end point assessments.

Phase 3 data show the C3 inhibitors' sustained benefit for the common form of vision loss. A primary author explains the significance of the new findings.

AI-based screening for ROP may be more cost-effective than traditional screening modalities, but depends significantly on the added cost of AI.

Patients who screened positive for depression had worse dry eye symptoms and overall signs but similar inflammatory markers compared to those negative for depression.

Children with strabismus had higher odds of having anxiety disorder, schizophrenia, bipolar disorder, and depressive disorder compared to those without eye diseases.

An increase in annual prevalence of beneficiaries with diabetes was observed in those who had ≥1 claim for DME (1.0% to 3.3%) and DME/VTDR (2.8% to 4.3%).

AGN-190584 showed superiority in efficacy over vehicle in mesopic DCNVA on day 30 with an acceptable safety profile for patients with presbyopia.